United States of America
Dr. Johnson has been the Director of Chemistry at Hawaii Biotech Inc since 2013. Previously, he was the Director of Chemistry at PanThera Biopharma from 2006 to 2013. During this time he has been the Principal Investigator for several NIH grants involved with the discovery of small molecule therapeutics to treat diseases related to Biodefense. Prior to this, Dr. Johnson was a Group Leader at X-Ceptor Therapeutics where he focused on the discovery of small molecule modulators of the nuclear receptor LXR to treat metabolic disease. He began his professional career at Allergan Inc. working in the area of the nuclear receptors where his work led to the identification of RAR subtype specific agonists and antagonists. He has coauthored numerous articles in the area of organic and medicinal chemistry, and is a coauthor on multiple issued patents. Dr. Johnson completed an NIH post-doctoral fellowship at the University of Rochester after obtaining his Ph.D. in synthetic organic chemistry at Oregon State University, a M.S in physical organic chemistry at San Diego State University, and his B.A. in chemistry at UC San Diego.
Infectious Diseases & Preventive Medicine Clinical & Experimental Ophthalmology